"","scenario","cases","severe_disease","hosp","death","YLL"
"1","25% prioritisation"," -15,543 (-0.2%)","  -1,419 (-5%)","  -2,965 (-2.2%)","    -156 (-7.6%)","  -1,457 (-5.2%)"
"2","50% prioritisation"," -13,656 (-0.1%)","  -1,462 (-5.1%)","  -3,024 (-2.3%)","    -162 (-7.8%)","  -1,502 (-5.4%)"
"3","75% prioritisation"," -12,513 (-0.1%)","  -1,474 (-5.2%)","  -3,036 (-2.3%)","    -163 (-7.9%)","  -1,516 (-5.5%)"
"4","booster at three months (at risk only)"," -96,437 (-1%)","  -6,739 (-23.6%)"," -13,859 (-10.3%)","    -720 (-34.9%)","  -6,749 (-24.3%)"
"5","additional primary doses"," -23,724 (-0.2%)","  -1,519 (-5.3%)","  -3,317 (-2.5%)","    -163 (-7.9%)","  -1,543 (-5.6%)"
"6","additional booster doses","-123,242 (-1.3%)","  -6,738 (-23.6%)"," -14,528 (-10.8%)","    -700 (-34%)","  -6,663 (-24%)"
"7","broaden to <18 pregnant individuals"," -23,724 (-0.2%)","  -1,519 (-5.3%)","  -3,317 (-2.5%)","    -163 (-7.9%)","  -1,543 (-5.6%)"
